Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-Qing He

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Microbial Pathogenesis|May 19, 2026
Association Between Immunosenescence and High Bacterial Load in Elderly Patients with Pulmonary Tuberculosis: A Retrospective Cohort Study Conducted in Southwest China, 2013-2020Jing Cheng, Daoyan Tang, Shijia Hong, et al.
Therapie|August 11, 2018
Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injuryShouquan Wu, Yu Wang, Miaomiao Zhang, et al.
Bioscience Reports|July 29, 2018
Polymorphisms of the <i>STAT4</i> gene in the pathogenesis of tuberculosisShouquan Wu, Minggui Wang, Yu Wang, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|July 18, 2020
[Association of rs1495741 Single Nucleotide Polymorphism with Susceptibility of Anti-tuberculosis Drug-induced Hepatotoxicity]Ming-Gui Wang, Yao-Zhi Zhang, Meng Zhang, et al.
Microbes and Infection|July 6, 2022
Impacts of clofazimine on the treatment outcomes of drug-resistant tuberculosisMing-Gui Wang, Xiang-Min Liu, Shou-Quan Wu, et al.
Frontiers in Pharmacology|November 17, 2022
Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injuryMing-Gui Wang, Shou-Quan Wu, Meng-Meng Zhang, et al.
The Journal of Infection|February 17, 2026
ANKRD22 as a Novel Diagnostic Biomarker and Immunomodulator in Tuberculosis Disease: A Multi-Cohort and Clinical Validation StudyQing-Qing Shan, Meng Luo, YongXian Zhang, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2003
Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokersJian-Qing He, John E Connett, Nicholas R Anthonisen, et al.
British Journal of Clinical Pharmacology|January 14, 2026
Plasma proteomics biomarkers for predicting anti-tuberculosis drug-induced liver injury: A comprehensive assessmentMing-Gui Wang, Meng-Meng Zhang, Quan-Xian Liu, et al.
World Journal of Psychiatry|March 20, 2025
Combined microscopic and neuroendoscopic treatment effects on psychological and cognitive outcomes in ruptured intracranial aneurysmsLi-Ke Shi, Xian-Feng Cai, Jian-Qing He, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Microbial Pathogenesis|May 19, 2026
Association Between Immunosenescence and High Bacterial Load in Elderly Patients with Pulmonary Tuberculosis: A Retrospective Cohort Study Conducted in Southwest China, 2013-2020Jing Cheng, Daoyan Tang, Shijia Hong, et al.
Therapie|August 11, 2018
Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injuryShouquan Wu, Yu Wang, Miaomiao Zhang, et al.
Bioscience Reports|July 29, 2018
Polymorphisms of the <i>STAT4</i> gene in the pathogenesis of tuberculosisShouquan Wu, Minggui Wang, Yu Wang, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|July 18, 2020
[Association of rs1495741 Single Nucleotide Polymorphism with Susceptibility of Anti-tuberculosis Drug-induced Hepatotoxicity]Ming-Gui Wang, Yao-Zhi Zhang, Meng Zhang, et al.
Microbes and Infection|July 6, 2022
Impacts of clofazimine on the treatment outcomes of drug-resistant tuberculosisMing-Gui Wang, Xiang-Min Liu, Shou-Quan Wu, et al.
Frontiers in Pharmacology|November 17, 2022
Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injuryMing-Gui Wang, Shou-Quan Wu, Meng-Meng Zhang, et al.
The Journal of Infection|February 17, 2026
ANKRD22 as a Novel Diagnostic Biomarker and Immunomodulator in Tuberculosis Disease: A Multi-Cohort and Clinical Validation StudyQing-Qing Shan, Meng Luo, YongXian Zhang, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2003
Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokersJian-Qing He, John E Connett, Nicholas R Anthonisen, et al.
British Journal of Clinical Pharmacology|January 14, 2026
Plasma proteomics biomarkers for predicting anti-tuberculosis drug-induced liver injury: A comprehensive assessmentMing-Gui Wang, Meng-Meng Zhang, Quan-Xian Liu, et al.
World Journal of Psychiatry|March 20, 2025
Combined microscopic and neuroendoscopic treatment effects on psychological and cognitive outcomes in ruptured intracranial aneurysmsLi-Ke Shi, Xian-Feng Cai, Jian-Qing He, et al.
Pageof 11